All Stocks
C

CGON

CG Oncology, Inc. Common stock
Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$67.48

Market Cap

$5.70B

Beta

1.19

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+254.70%
EPS Growth (YoY)-61.24%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio—
FCF Yield-2.33%
Debt / Equity0.01
Interest Coverage999.0x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for CGON.

CGON — CG Oncology, Inc. Common stock Stock Analysis | Tessera Alpha